Al's Comment:

 Although median survival wasn't helped much, 10% were alive at 4 years and one was progression free at 5 years.


Posted on: 08/16/2022

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click
HERE to read it!